Efficacy and Safety of Vodobatinib in Patients (pts) with Chronic Phase Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML): A Sub Group Analysis By Lines of Tyrosine Kinase Inhibitor (TKI) Therapy
Saved in:
Published in | Blood Vol. 140; no. Supplement 1; pp. 205 - 207 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
15.11.2022
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!